Listed

Vanda Pharmaceuticals Inc.

VNDANasdaqCIK 1347178HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$69.8m, Q3 FY2026
Operating income−$23.5m, Q3 FY2026
Net income−$22.6m, Q3 FY2026
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m45.3Revenue, Q4 FY2023, three months to 2023-12-31$45.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure47.5Revenue, Q1 FY2024, three months to 2024-03-31$47.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure50.5Revenue, Q2 FY2024, three months to 2024-06-30$50.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure47.7Revenue, Q3 FY2024, three months to 2024-09-30$47.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure53.2Revenue, Q4 FY2024, three months to 2024-12-31$53.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure50.0Revenue, Q1 FY2025, three months to 2025-03-31$50.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure52.6Revenue, Q2 FY2025, three months to 2025-06-30$52.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure56.3Revenue, Q3 FY2025, three months to 2025-09-30$56.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure57.2Revenue, Q4 FY2025, three months to 2025-12-31$57.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure51.7Revenue, Q1 FY2026, three months to 2026-03-31$51.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure50.5Revenue, Q2 FY2026, three months to 2026-06-30$50.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure69.8Revenue, Q3 FY2026, three months to 2026-09-30$69.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m24.3Research and development, Q4 FY2023, three months to 2023-12-31$24.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure21.2Research and development, Q1 FY2024, three months to 2024-03-31$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure16.7Research and development, Q2 FY2024, three months to 2024-06-30$16.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure16.8Research and development, Q3 FY2024, three months to 2024-09-30$16.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure19.8Research and development, Q4 FY2024, three months to 2024-12-31$19.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure35.7Research and development, Q1 FY2025, three months to 2025-03-31$35.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure22.0Research and development, Q2 FY2025, three months to 2025-06-30$22.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure22.6Research and development, Q3 FY2025, three months to 2025-09-30$22.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure29.0Research and development, Q4 FY2025, three months to 2025-12-31$29.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure28.4Research and development, Q1 FY2026, three months to 2026-03-31$28.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure37.0Research and development, Q2 FY2026, three months to 2026-06-30$37.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure27.6Research and development, Q3 FY2026, three months to 2026-09-30$27.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Selling, general and administrative$m23.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$23.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure30.1Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$30.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure39.5Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$39.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure37.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$37.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure39.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$39.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure50.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$50.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure64.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$64.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure60.3Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$60.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure63.0Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$63.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure68.4Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$68.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure71.8Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$71.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure59.6Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$59.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Operating income$m(7.1)Operating income, Q4 FY2023, three months to 2023-12-31−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(9.2)Operating income, Q1 FY2024, three months to 2024-03-31−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure(10.1)Operating income, Q2 FY2024, three months to 2024-06-30−$10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure(11.0)Operating income, Q3 FY2024, three months to 2024-09-30−$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure(10.3)Operating income, Q4 FY2024, three months to 2024-12-31−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(41.0)Operating income, Q1 FY2025, three months to 2025-03-31−$41.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(38.5)Operating income, Q2 FY2025, three months to 2025-06-30−$38.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure(31.3)Operating income, Q3 FY2025, three months to 2025-09-30−$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure(40.4)Operating income, Q4 FY2025, three months to 2025-12-31−$40.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(50.2)Operating income, Q1 FY2026, three months to 2026-03-31−$50.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(63.8)Operating income, Q2 FY2026, three months to 2026-06-30−$63.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure(23.5)Operating income, Q3 FY2026, three months to 2026-09-30−$23.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Income tax$m0.7Income tax, Q4 FY2023, three months to 2023-12-31$739.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Income tax, Q1 FY2024, three months to 2024-03-31−$518.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure(1.0)Income tax, Q2 FY2024, three months to 2024-06-30−$998.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure(0.9)Income tax, Q3 FY2024, three months to 2024-09-30−$920.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure(1.6)Income tax, Q4 FY2024, three months to 2024-12-31−$1.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(7.9)Income tax, Q1 FY2025, three months to 2025-03-31−$7.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(7.7)Income tax, Q2 FY2025, three months to 2025-06-30−$7.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure(5.8)Income tax, Q3 FY2025, three months to 2025-09-30−$5.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure103Income tax, Q4 FY2025, three months to 2025-12-31$103.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$143.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$129.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure0.2Income tax, Q3 FY2026, three months to 2026-09-30$174.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Net income$m(2.4)Net income, Q4 FY2023, three months to 2023-12-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(4.1)Net income, Q1 FY2024, three months to 2024-03-31−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure(4.5)Net income, Q2 FY2024, three months to 2024-06-30−$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure(5.3)Net income, Q3 FY2024, three months to 2024-09-30−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure(4.9)Net income, Q4 FY2024, three months to 2024-12-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(29.5)Net income, Q1 FY2025, three months to 2025-03-31−$29.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure(27.2)Net income, Q2 FY2025, three months to 2025-06-30−$27.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure(22.6)Net income, Q3 FY2025, three months to 2025-09-30−$22.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure(141)Net income, Q4 FY2025, three months to 2025-12-31−$141.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(48.6)Net income, Q1 FY2026, three months to 2026-03-31−$48.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure(62.5)Net income, Q2 FY2026, three months to 2026-06-30−$62.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure(22.6)Net income, Q3 FY2026, three months to 2026-09-30−$22.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Diluted EPS$ per sharenot reported(0.07)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure(0.08)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure(0.09)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figurenot reported(0.50)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(0.46)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure(0.38)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figurenot reported(0.82)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(1.04)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure(0.37)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Basic EPS$ per sharenot reported(0.07)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure(0.08)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure(0.09)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figurenot reported(0.50)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(0.46)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure(0.38)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figurenot reported(0.82)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(1.04)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure(0.37)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure

Balance sheet

Cash and equivalents$61.9m, Q3 FY2026
Shareholders' equity$199.9m, Q3 FY2026
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m136Cash and equivalents, FY2023, at 2023-12-31$135.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-14, accession 0001628280-25-005761.Report this figure125Cash and equivalents, Q1 FY2024, at 2024-03-31$125.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure103Cash and equivalents, Q2 FY2024, at 2024-06-30$103.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure100Cash and equivalents, Q3 FY2024, at 2024-09-30$100.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure102Cash and equivalents, FY2024, at 2024-12-31$102.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-12, accession 0001628280-26-007460.Report this figure112Cash and equivalents, Q1 FY2025, at 2025-03-31$111.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure81.0Cash and equivalents, Q2 FY2025, at 2025-06-30$81.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure70.0Cash and equivalents, Q3 FY2025, at 2025-09-30$70.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure84.9Cash and equivalents, FY2025, at 2025-12-31$84.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure54.0Cash and equivalents, Q1 FY2026, at 2026-03-31$54.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure55.9Cash and equivalents, Q2 FY2026, at 2026-06-30$55.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure61.9Cash and equivalents, Q3 FY2026, at 2026-09-30$61.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Current assets$m433Current assets, FY2023, at 2023-12-31$432.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-14, accession 0001628280-25-005761.Report this figure439Current assets, Q1 FY2024, at 2024-03-31$439.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001628280-24-021952.Report this figure439Current assets, Q2 FY2024, at 2024-06-30$439.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0001628280-24-033866.Report this figure432Current assets, Q3 FY2024, at 2024-09-30$432.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001628280-24-045970.Report this figure439Current assets, FY2024, at 2024-12-31$438.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-12, accession 0001628280-26-007460.Report this figure408Current assets, Q1 FY2025, at 2025-03-31$407.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure395Current assets, Q2 FY2025, at 2025-06-30$394.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure367Current assets, Q3 FY2025, at 2025-09-30$367.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure347Current assets, FY2025, at 2025-12-31$347.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure293Current assets, Q1 FY2026, at 2026-03-31$293.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure264Current assets, Q2 FY2026, at 2026-06-30$264.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure238Current assets, Q3 FY2026, at 2026-09-30$238.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Total assets$m648Total assets, FY2023, at 2023-12-31$648.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-14, accession 0001628280-25-005761.Report this figure653Total assets, Q1 FY2024, at 2024-03-31$652.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001628280-24-021952.Report this figure651Total assets, Q2 FY2024, at 2024-06-30$651.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0001628280-24-033866.Report this figure645Total assets, Q3 FY2024, at 2024-09-30$645.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001628280-24-045970.Report this figure656Total assets, FY2024, at 2024-12-31$656.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-12, accession 0001628280-26-007460.Report this figure632Total assets, Q1 FY2025, at 2025-03-31$631.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure625Total assets, Q2 FY2025, at 2025-06-30$624.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure601Total assets, Q3 FY2025, at 2025-09-30$601.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure489Total assets, FY2025, at 2025-12-31$488.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure434Total assets, Q1 FY2026, at 2026-03-31$433.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure412Total assets, Q2 FY2026, at 2026-06-30$412.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure382Total assets, Q3 FY2026, at 2026-09-30$382.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Current liabilities$m87.7Current liabilities, FY2023, at 2023-12-31$87.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-14, accession 0001628280-25-005761.Report this figure93.3Current liabilities, Q1 FY2024, at 2024-03-31$93.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001628280-24-021952.Report this figure93.8Current liabilities, Q2 FY2024, at 2024-06-30$93.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0001628280-24-033866.Report this figure89.1Current liabilities, Q3 FY2024, at 2024-09-30$89.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001628280-24-045970.Report this figure100.0Current liabilities, FY2024, at 2024-12-31$100.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-12, accession 0001628280-26-007460.Report this figure104Current liabilities, Q1 FY2025, at 2025-03-31$103.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure121Current liabilities, Q2 FY2025, at 2025-06-30$121.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure118Current liabilities, Q3 FY2025, at 2025-09-30$117.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure145Current liabilities, FY2025, at 2025-12-31$145.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure136Current liabilities, Q1 FY2026, at 2026-03-31$135.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure164Current liabilities, Q2 FY2026, at 2026-06-30$164.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure155Current liabilities, Q3 FY2026, at 2026-09-30$155.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Total liabilities$m104Total liabilities, FY2023, at 2023-12-31$103.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-14, accession 0001628280-25-005761.Report this figure109Total liabilities, Q1 FY2024, at 2024-03-31$108.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001628280-24-021952.Report this figure109Total liabilities, Q2 FY2024, at 2024-06-30$108.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0001628280-24-033866.Report this figure104Total liabilities, Q3 FY2024, at 2024-09-30$103.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001628280-24-045970.Report this figure118Total liabilities, FY2024, at 2024-12-31$117.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-12, accession 0001628280-26-007460.Report this figure121Total liabilities, Q1 FY2025, at 2025-03-31$120.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure138Total liabilities, Q2 FY2025, at 2025-06-30$138.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure135Total liabilities, Q3 FY2025, at 2025-09-30$135.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure162Total liabilities, FY2025, at 2025-12-31$161.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure153Total liabilities, Q1 FY2026, at 2026-03-31$152.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure192Total liabilities, Q2 FY2026, at 2026-06-30$192.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure182Total liabilities, Q3 FY2026, at 2026-09-30$182.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure
Shareholders' equity$m545Shareholders' equity, FY2023, at 2023-12-31$544.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-12, accession 0001628280-26-007460.Report this figure544Shareholders' equity, Q1 FY2024, at 2024-03-31$544.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure543Shareholders' equity, Q2 FY2024, at 2024-06-30$542.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure541Shareholders' equity, Q3 FY2024, at 2024-09-30$541.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure539Shareholders' equity, FY2024, at 2024-12-31$538.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure511Shareholders' equity, Q1 FY2025, at 2025-03-31$511.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure486Shareholders' equity, Q2 FY2025, at 2025-06-30$486.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure466Shareholders' equity, Q3 FY2025, at 2025-09-30$466.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure327Shareholders' equity, FY2025, at 2025-12-31$327.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure281Shareholders' equity, Q1 FY2026, at 2026-03-31$280.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure220Shareholders' equity, Q2 FY2026, at 2026-06-30$220.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure200Shareholders' equity, Q3 FY2026, at 2026-09-30$199.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure

Cash flow

Operating cash flow−$28.4m, Q3 FY2026
Capital expenditure$311.0k, Q3 FY2026
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(3.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure7.6Operating cash flow, Q1 FY2024, three months to 2024-03-31$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure(6.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0001628280-25-036861. Derived: 6-month figure less the 3-month figure.Report this figure(14.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001628280-25-047317. Derived: 9-month figure less the 6-month figure.Report this figure(1.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(33.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$33.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(15.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-053855. Derived: 6-month figure less the 3-month figure.Report this figure(31.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$31.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001347178-26-000002. Derived: 9-month figure less the 6-month figure.Report this figure(29.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$29.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure(50.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$50.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure(31.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$31.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-053855. Derived: 6-month figure less the 3-month figure.Report this figure(28.4)Operating cash flow, Q3 FY2026, three months to 2026-09-30−$28.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001347178-26-000002. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$253.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$108.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0001628280-25-036861. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$161.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001628280-25-047317. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$214.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$436.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure0.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$299.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-053855. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$161.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001347178-26-000002. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$102.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001628280-26-007460. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$221.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$190.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-053855. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2026, three months to 2026-09-30$311.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001347178-26-000002. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)60.47m, Q3 FY2026
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares57.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3157,400,152 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001628280-24-021952.Report this figure57.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3057,535,615 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0001628280-24-033866.Report this figure57.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3057,595,344 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001628280-24-045970.Report this figure57.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3157,760,940 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001628280-25-023448.Report this figure58.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3058,220,838 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-31, accession 0001628280-25-036861.Report this figure58.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3058,261,961 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001628280-25-047317.Report this figure58.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3158,527,775 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure59.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3058,993,990 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure59.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3059,091,478 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure59.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3159,459,982 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628280-26-031667.Report this figure60.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3060,226,570 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-053855.Report this figure60.5Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3060,465,170 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure

Shares outstanding: 60.47mShares outstanding, period not labelled, at 2026-10-2260,469,687 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-29, accession 0001347178-26-000002.Report this figure at Oct 22, 2026, from the cover of the 10-Q filed Oct 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:08 ET. Listed shows no prices and gives no investment advice.